Internal Medicine, Cardiovascular Disease · San Jose, CA
NPI
1932291648
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 Jose Figueres Ave, #330
San Jose, CA, 95116
Phone (408) 251-7900
Groups this clinician bills Medicare through
Medicare paid, 2024
$591K
3,279 services
Medicare patients, 2024
719
Average age 78
Drug cost, 2024
$2.0M
7,818 prescriptions
Company payments, 2025
$1,512
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John H Lien was code 99214 (office e&m - established), 1,096 times for 654 patients. In total John H Lien billed 3,279 services in 30 codes, and Medicare paid $591K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,096 | 654 | $108.87 | $119K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 592 | 146 | $5.52 | $3,270 |
| 93000 Electrocardiogram | Office | 291 | 261 | $12.69 | $3,694 |
| 93306 Echocardiography (TTE/TEE) | Office | 242 | 238 | $201.77 | $49K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 234 | 115 | $407.86 | $95K |
| 93015 Electrocardiogram | Office | 154 | 153 | $70.42 | $11K |
| 99204 Office E&M - New | Office | 119 | 119 | $128.95 | $15K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 77 | 39 | $178.69 | $14K |
| 78434 Myocardial Perfusion Scan | Office | 63 | 62 | $139.90 | $8,814 |
| 78431 Myocardial Perfusion Scan | Office | 62 | 62 | $1,993.76 | $124K |
| 78492 Myocardial Perfusion Scan | Office | 54 | 54 | $1,568.74 | $85K |
| 93280 External Electrocardiographic Monitoring | Office | 53 | 27 | $69.57 | $3,687 |
| J0280 Injection, aminophyllin, up to 250 mg | Office | 53 | 52 | $6.10 | $323 |
| 78452 Myocardial Perfusion Scan | Office | 39 | 39 | $467.85 | $18K |
| 99215 Office E&M - Established | Office | 30 | 28 | $164.09 | $4,923 |
By year: 2022 $737K for 12,556 services; 2023 $738K for 7,072 services; 2024 $591K for 3,279 services.
Medicare prescription drug claims, 2024
In 2024, the drug John H Lien prescribed most often to Medicare patients was Metoprolol Succinate, with 830 prescriptions and refills. In total John H Lien wrote 7,818 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 830 | 2,337 | 303 | $13K |
| Eliquis Apixaban | 730 | 1,251 | 163 | $727K |
| Rosuvastatin Calcium Generic | 620 | 1,751 | 246 | $9,759 |
| Atorvastatin Calcium Generic | 579 | 1,593 | 188 | $6,749 |
| Amlodipine Besylate Generic | 462 | 1,301 | 178 | $3,517 |
| Olmesartan Medoxomil Generic | 406 | 1,127 | 174 | $6,339 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 373 | 1,071 | 160 | $18K |
| Nitroglycerin Generic | 348 | 411 | 171 | $2,854 |
| Xarelto Rivaroxaban | 329 | 554 | 69 | $297K |
| Clopidogrel Clopidogrel Bisulfate | 322 | 911 | 125 | $4,250 |
| Ezetimibe Generic | 306 | 870 | 115 | $7,964 |
| Entresto Sacubitril/Valsartan | 187 | 342 | 55 | $226K |
| Losartan Potassium Generic | 168 | 487 | 70 | $1,456 |
| Vascepa Icosapent Ethyl | 163 | 289 | 48 | $103K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 137 | 386 | 44 | $1,877 |
Brand drugs: 2,087 claims; generic drugs: 5,731 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John H Lien $1,512 ($1,512 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novo Nordisk Inc with $352.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 14 | $352 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $296 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $239 |
| Boston Scientific Corporation BSX | 5 | $208 |
| Merck Sharp & Dohme LLC MRK | 6 | $160 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $83.29 |
| Amgen Inc. AMGN | 3 | $82.33 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $43.81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.92 |
| Abbott Laboratories ABT | 1 | $23.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.